KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Current Deferred Revenue (2017 - 2025)

Guardant Health (GH) has disclosed Current Deferred Revenue for 9 consecutive years, with $50.8 million as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue rose 22.0% to $50.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $50.8 million through Dec 2025, up 22.0% year-over-year, with the annual reading at $50.8 million for FY2025, 22.0% up from the prior year.
  • Current Deferred Revenue hit $50.8 million in Q4 2025 for Guardant Health, down from $56.4 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $56.4 million in Q3 2025 to a low of $7.3 million in Q3 2021.
  • Historically, Current Deferred Revenue has averaged $24.9 million across 5 years, with a median of $17.7 million in 2022.
  • Biggest five-year swings in Current Deferred Revenue: dropped 29.96% in 2021 and later soared 189.29% in 2024.
  • Year by year, Current Deferred Revenue stood at $11.3 million in 2021, then skyrocketed by 53.66% to $17.4 million in 2022, then grew by 3.23% to $18.0 million in 2023, then soared by 131.56% to $41.6 million in 2024, then increased by 22.0% to $50.8 million in 2025.
  • Business Quant data shows Current Deferred Revenue for GH at $50.8 million in Q4 2025, $56.4 million in Q3 2025, and $54.4 million in Q2 2025.